MADISON DEARBORN PARTNERS / THOMA BRAVO to acquire NEXTGEN HEALTHCARE

MADISON DEARBORN PARTNERS and THOMA BRAVO have agreed to acquire NEXTGEN HEALTHCARE in a private equity acquisition. The transaction was announced on 4 May 2025. The target operates within the information technology sector, specifically under the NaceV2Sector_K_62.1 classification. No specific deal value or currency was disclosed in the available records. The consideration structure remains unreported, and the target country is not specified in the current data set.

The deal involves two major private equity firms combining their resources to purchase the healthcare technology business. As the transaction is currently in regulatory review, the completion date has not yet been confirmed. The parties are proceeding with the necessary steps to finalise the acquisition of the company. The transaction is subject to regulatory approval.